Salkind Gene
Coeptis Therapeutics Holdings, Inc. · Director
Salkind Gene is listed in public filings as director. This Salkind Gene insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Coeptis Therapeutics Holdings, Inc. (COEPW), and Upexi, Inc. (UPXI). Investors use Salkind Gene's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| --13.2k shares | Grant / ExerciseFeb 11, 2026 | Disclosure amount unavailable3.3k shares | -- | -- | |
| $139k13.2k shares | Grant / ExerciseFeb 11, 2026 | $60.2K5.7k shares | $10.56 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $558k218.8k shares | BuyNov 20, 2025 | $127.5K50k shares | $2.55 | -- | |
| $474k168.8k shares | BuyNov 17, 2025 | $281.0K100k shares | $2.81 | -- | |
| $1.5M569.5k shares | BuyNov 17, 2025 | $265.0K100k shares | $2.65 | -- | |
| --435.4k shares | Grant / ExerciseJul 16, 2025 | Disclosure amount unavailable50k shares | -- | -- | |
| --585.4k shares | Grant / ExerciseJul 16, 2025 | Disclosure amount unavailable150k shares | -- | -- | |
| $1.9M385.4k shares | BuyJul 11, 2025 | $100.0K20.2k shares | $4.94 | -- | |
| $832k365.1k shares | BuyApr 17, 2025 | $550.0K241.2k shares | $2.28 | -- | |
| $80k35k shares | Grant / ExerciseApr 17, 2025 | $79.8K35k shares | $2.28 | -- | |
| $95k9k shares | Grant / ExerciseMar 4, 2025 | $60.2K5.7k shares | $10.56 | -- | |
| $87k25k shares | Grant / ExerciseJan 17, 2025 | $86.5K25k shares | $3.46 | -- |